GENEVA, Sept. 18 -- STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM filed a patent application (IB2026/052208) for “COMBINATIONS OF SOTORASIB AND RIVAROXABAN FOR USE IN THE TREATMENT OF KRAS G12C MUTATED CANCERS”. With publication no. WO/2026/185814, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/5377
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....